Catalyst Biosciences, Inc. Stock price
Is Catalyst Biosciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,143 stocks worldwide.
Key metrics
Catalyst Biosciences, Inc. Stock Analysis
Analyst Opinions
7 Analysts have issued a Catalyst Biosciences, Inc. forecast:
Analyst Opinions
7 Analysts have issued a Catalyst Biosciences, Inc. forecast:
Don't miss a Thing! We will send you all news about Catalyst Biosciences, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Catalyst Biosciences, Inc. Stock News
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.
| Head office | United States |
| CEO | Mr. Puccetti |
| Employees | 28 |
| Founded | 1997 |
| Website | www.cosciensbio.com |


